Description

Description

Galvecta Plus (50mg/850mg) is a fixed-dose combination medicine manufactured by PharmaEvo, formulated with Vildagliptin 50mg and Metformin 850mg in each tablet. This pack contains 14 tablets and represents an intermediate-strength option within the Galvecta Plus range, positioned above the base combination dose, for adults with type 2 diabetes mellitus who need a moderately stronger Metformin component alongside the DPP-4 inhibiting action of Vildagliptin. This strength is often selected for patients who are being stepped up from a lower Metformin dose or who need finer dose adjustment based on their glycemic response and tolerability. Vildagliptin works by increasing levels of natural hormones that prompt the pancreas to release more insulin when blood sugar is high while also reducing glucose production by the liver, offering a relatively gentle safety profile with a lower likelihood of causing significant drops in blood sugar on its own. Metformin complements this by further lowering liver glucose output and improving the body’s sensitivity to insulin. Combining these two mechanisms into a single tablet is intended to simplify treatment regimens while supporting more thorough blood sugar control. Galvecta Plus should always be used as part of a broader diabetes management plan that includes appropriate diet, physical activity, and regular blood sugar monitoring, and only under the ongoing supervision of a qualified healthcare provider.

Ingredients

Each tablet of Galvecta Plus (50/850mg) contains two active pharmaceutical ingredients: Vildagliptin 50mg, a DPP-4 inhibitor that supports insulin release and reduces liver glucose production, and Metformin Hydrochloride 850mg, a biguanide-class antidiabetic agent that decreases hepatic glucose production and enhances insulin sensitivity in body tissues. The formulation also contains standard pharmaceutical excipients, including binding and film-coating agents, which support the tablet’s physical stability and help ensure consistent and reliable release of both active ingredients.

Dosage Form

Galvecta Plus (50/850mg) is available as an oral film-coated tablet, with each tablet delivering a combined strength of 50mg Vildagliptin and 850mg Metformin. The pack contains 14 tablets, offering a dosage option suited to patients requiring a mid-range Metformin strength as part of their diabetes treatment plan, as determined by a physician.

Uses

Galvecta Plus (50/850mg) is used to help improve blood sugar control in adults with type 2 diabetes mellitus, particularly for patients who require a moderate increase in Metformin dosage combined with the added glucose-lowering effect of Vildagliptin. It is often prescribed as a step between lower and higher combination strengths, allowing physicians to fine-tune treatment based on individual response and tolerability. It may also be used alongside other antidiabetic medicines as part of a broader treatment strategy. This medicine is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

How to Use

Galvecta Plus tablets are generally taken twice daily with meals, as directed by a doctor, which helps reduce the likelihood of gastrointestinal discomfort associated with the Metformin component. Tablets should be swallowed whole with a glass of water and should not be crushed, split, or chewed unless specifically advised by a healthcare provider. Dosage and treatment duration should strictly follow the physician’s prescription, as these are individualized based on factors such as kidney and liver function, current blood sugar levels, and other medications in use. If a dose is missed, it should be taken as soon as remembered, unless it is close to the time of the next scheduled dose, in which case the missed dose should be skipped rather than doubled.

Side Effects

Galvecta Plus (50/850mg) may cause side effects in some individuals, though not everyone will experience them. Commonly reported effects include gastrointestinal symptoms such as nausea, diarrhea, and stomach discomfort, particularly when treatment is first started, along with dizziness and headache associated with the Vildagliptin component. Some patients may also notice mild joint discomfort or a metallic taste in the mouth. In rare cases, more serious effects such as lactic acidosis (linked to Metformin), significant liver problems, or pancreatitis (linked to Vildagliptin) may occur, requiring immediate medical attention if symptoms such as severe abdominal pain, persistent nausea, unusual fatigue, or yellowing of the skin or eyes appear.

Pregnancy & Breastfeeding

Galvecta Plus (50/850mg) is generally not recommended for use during pregnancy. While Metformin has been used in specific pregnancy-related circumstances under close medical supervision, the safety of Vildagliptin during pregnancy has not been well established, and insulin is typically preferred for blood sugar management during this period. Women who are pregnant, planning pregnancy, or suspect they may be pregnant should inform their doctor without delay. The safety of this combination during breastfeeding has not been well established, and alternative diabetes management options are generally considered for nursing mothers. Any decision regarding use during pregnancy or breastfeeding should be made only in consultation with a qualified healthcare provider.

Storage Instructions

Galvecta Plus tablets should be stored at room temperature in a cool, dry place, protected from direct sunlight, heat, and excess moisture. Tablets should remain in their original packaging until use to guard against environmental exposure. Keep the medicine out of reach of children and pets, and avoid using it beyond the expiry date printed on the pack. Any unused or expired tablets should be disposed of responsibly in line with local pharmaceutical disposal guidelines, rather than being thrown away with regular household waste.

FAQs

Why does Galvecta Plus come in a 850mg Metformin strength specifically?
The 850mg strength offers a mid-range Metformin dose, allowing doctors to adjust treatment gradually between lower and higher combination options based on how a patient responds.

Should this medicine be taken with food?
Yes, taking it with meals is generally recommended to help minimize gastrointestinal discomfort that can occur with the Metformin component.

Can I switch from a different Galvecta Plus strength to this one?
Any change in strength should only be made under a doctor’s supervision, as it may involve dose adjustment and monitoring of blood sugar, kidney, and liver function.

Is regular monitoring required while taking this medicine?
Yes, periodic monitoring of blood sugar levels and kidney and liver function is generally recommended for patients on this combination therapy, as advised by their healthcare provider.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.